BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/07/2026

FDA Extends Comment Period for Expedited IND Pilot Program Proposal

The FDA is extending the comment period for a proposal to establish a pilot program that aims to shorten the time it takes to bring new drugs to market while protecting clinical trial participants, in response to a request for information from the public.

Source: Federal Register — Health and Human ServicesOpen original release →